These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 82285)

  • 21. Bone marrow acid phosphatase by radioimmunoassay.
    Belville WD; Cox HD; Mahan DE; Olmert JP; Mittemeyer BT; Bruce AW
    Cancer; 1978 Jun; 41(6):2286-91. PubMed ID: 77719
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunohistochemical evaluation of prostatic carcinoma before and after radiotherapy.
    Mahan DE; Bruce AW; Manley PN; Franchi L
    J Urol; 1980 Oct; 124(4):488-91. PubMed ID: 6158585
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The histochemical behaviour, electrophoretic mobility and distribution in cell fractions of acid phosphatase isozymes in prostatic cancer and benign prostate hyperplasia.
    Fischer DR; Gevers W; Klerk JN; Kühn S
    Int Urol Nephrol; 1979; 11(2):111-8. PubMed ID: 89105
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Matrix metalloproteinase 9 expression in primary human prostatic adenocarcinoma and benign prostatic hyperplasia.
    Hamdy FC; Fadlon EJ; Cottam D; Lawry J; Thurrell W; Silcocks PB; Anderson JB; Williams JL; Rees RC
    Br J Cancer; 1994 Jan; 69(1):177-82. PubMed ID: 7506923
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunohistochemical analysis of type IV collagenase expression in prostatic hyperplasia and adenocarcinoma.
    Boag AH; Young ID
    Mod Pathol; 1993 Jan; 6(1):65-8. PubMed ID: 7678936
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enzyme markers in human prostatic carcinoma.
    Chu TM; Wang MC; Kuciel R; Valenzuela L; Murphy GP
    Cancer Treat Rep; 1977; 61(2):193-200. PubMed ID: 68822
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of human prostatic acid phosphatase and prostate specific antigen genes in neoplastic and benign tissues.
    Sharief FS; Mohler JL; Sharief Y; Li SS
    Biochem Mol Biol Int; 1994 Jun; 33(3):567-74. PubMed ID: 7524903
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effects of various manipulations on serum phosphatase levels in benign disease.
    Greene FT; Thompson IM
    J Urol; 1974 Aug; 112(2):232-6. PubMed ID: 4135604
    [No Abstract]   [Full Text] [Related]  

  • 29. [Value of determining prostatic acid phosphatases by a radioimmunological method in cases of bony metastases].
    Mattei JP; Imbert I; Laugier-Catenacci E; Roux H
    Rev Rhum Mal Osteoartic; 1989 Feb; 56(2):147-9. PubMed ID: 2471253
    [No Abstract]   [Full Text] [Related]  

  • 30. Reverse transcriptase activity in extracts of human prostatic tissues.
    Job L; Carter WA; Arya SK
    Oncology; 1978; 35(5):202-5. PubMed ID: 82926
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Elevation of serum prostatic acid phosphatase levels after prostatic massage.
    Wadström J; Huber P; Rutishauser G
    Urology; 1984 Dec; 24(6):550-1. PubMed ID: 6209846
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Beta-glucuronidase activity in prostatic carcinoma and benign prostatic hyperplasia.
    Pearson JP; Pretlow TP; Bradley EL; McGinnis MC; Pretlow TG
    Cancer; 1989 Aug; 64(4):911-5. PubMed ID: 2472870
    [TBL] [Abstract][Full Text] [Related]  

  • 33. LDH isoenzymes in benign and malignant prostate tissue. The LDH V-I ratio as an index of malignancy.
    Oliver JA; el-Hilali MM; Belitsky P; MacKinnon KJ
    Cancer; 1970 Apr; 25(4):863-6. PubMed ID: 4191903
    [No Abstract]   [Full Text] [Related]  

  • 34. [Stomach neoplasm with a peculiar amylase isozyme pattern--a case study].
    Abiko H; Iwatake T; Harada Y; Kunishige K; Murakami H
    Nihon Shokakibyo Gakkai Zasshi; 1977 Mar; 74(3):362-8. PubMed ID: 558414
    [No Abstract]   [Full Text] [Related]  

  • 35. Hyperamylasemia in diabetic ketoacidosis: sources and significance.
    Vinicor F; Lehrner LM; Karn RC; Merritt AD
    Ann Intern Med; 1979 Aug; 91(2):200-4. PubMed ID: 111594
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lactic dehydrogenase isozymes in benign and malignant prostatic tissues.
    Srinivasan V; Keil E; Villalba R; Baron T; Clark SS
    Invest Urol; 1973 Nov; 11(3):244-7. PubMed ID: 4127178
    [No Abstract]   [Full Text] [Related]  

  • 37. Expression of protein kinase C isoenzymes in benign hyperplasia and carcinoma of prostate.
    Koren R; Ben Meir D; Langzam L; Dekel Y; Konichezky M; Baniel J; Livne PM; Gal R; Sampson SR
    Oncol Rep; 2004 Feb; 11(2):321-6. PubMed ID: 14719062
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of prostatic acid phosphatase assays.
    Wise WS; Kandaswamy K
    Arch Pathol Lab Med; 1981 Nov; 105(11):622-5. PubMed ID: 6170271
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acid phosphatase isozymes in cancer of the prostate.
    Reif AE; Schlesinger RM; Fish CA; Robinson CM
    Cancer; 1973 Mar; 31(3):689-99. PubMed ID: 4120927
    [No Abstract]   [Full Text] [Related]  

  • 40. Arginase activity in prostatic tissue of patients with benign prostatic hyperplasia and prostatic carcinoma.
    Harris BE; Pretlow TP; Bradley EL; Whitehurst GB; Pretlow TG
    Cancer Res; 1983 Jun; 43(6):3008-12. PubMed ID: 6189588
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.